Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BIOVIE INC
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
0
0
0
No Price
28.04.2026 20:00
Current Prices from BIOVIE INC
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
BIVI
USD
28.04.2026 20:00
1,58 USD
-0,01 USD
-0,63 %
IEX
BIVI
USD
28.04.2026 19:53
1,59 USD
-0,005 USD
-0,31 %
Share Float & Liquidity
Free Float99,47 %
Shares Float7,5 M
Shares Outstanding7,54 M
Company Profile for BIOVIE INC Share
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Carson City, Nevada.
